Saving your money for next purchases
Omalizumab alfa injection
Omashu® is approved for the treatment of moderate to severe persistent allergic asthma in patients aged 15 years and above whose symptoms cannot be effectively controlled after treatment with inhaled corticosteroids and long-acting β2-receptor agonists, providing a new treatment option for many allergic asthma patients.
Share:
Products
Our offers
Delivery – when you want and anywhere
A huge selection of best products
Health Classification
Let us work together to protect precious health
